A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.

Look to Beckman Coulter to deliver the most comprehensive yet easy-to-use tabletop ultracentrifuge platform available. The Optima MAX-XP Ultracentrifuge is a power-packed solution that delivers ...

Healthy.io, the global leader in transforming the smartphone camera into a medical device, announced the results of a new ...

By integrating Gibson SOLA’s high-fidelity, scalable, and non-toxic DNA synthesis capabilities with Beckman Coulter Life ...

Diagnostic company SphingoTec GmbH (“SphingoTec”) announced a new partnership with Beckman Coulter Diagnostics Inc. (“Beckman Coulter”). Through this collaboration, the companies will bring an assay ...

Per the agreement, Beckman Coulter will initially distribute BioPorto's NGAL test in Europe followed by distribution in the United States pending US Food and Drug Administration (FDA) marketing ...

With a relentless mission to empower those seeking answers to life’s important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation ...

Beckman has to tweak its lineup for the first found of the playoffs, but backup running back Aidan Tran and others show they ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

November 14, 2024Announcement no. 22 BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 Revenue growth and strategic execution COPENHAGEN, ...

there have been 52 years of successful innovation using the Coulter Principle, making Beckman Coulter one of the leading companies in particle characterization today. The Multisizer™ 4 features the ...

BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests COPENHAGEN, DENMARK and BOSTON, MA, USA, October 28, 2024 (GLOBE NEWSWIRE) – BioPorto A/S ...